Introduction
There is daily cyclic variation in our behaviour and physiology as humans have adapted to be awake during the day and sleep at night. This is especially relevant to our cardiovascular system, e.g. heart rate 1 and blood pressure 2 which peak in the day when we are active and reach a nadir at night when we are resting. Molecular circadian clocks in all cells, including cardiomyocytes, allow us to entrain to the external 24-h day/night cycle, and prepare for the differing physiologic demands of daily events. [3] [4] [5] [6] [7] The circadian clock mechanism at its most basic level consists of an auto-regulatory transcription and translation feedback loop which coordinates cellular function over the 24-h day/night cycle. Briefly, the positive limb consists of two transcription factors termed CLOCK and BMAL1 which heterodimerize and bind to E-box enhancer elements within the promoter region of circadian output genes such as Period (Per) and Cryptochrome (Cry). 8, 9 This drives transcription of the negative limb proteins PER and CRY. PER and CRY accumulate and in turn inhibit CLOCK: BMAL1 mediated transcription, thus repressing their own transcription. [8] [9] [10] A number of excellent reviews on the circadian clock mechanism have been previously published in. [11] [12] [13] The circadian mechanism is important for healthy cardiovascular physiology as disruption is associated with adverse consequences for the cardiovascular system. [14] [15] [16] Epidemiologic studies in humans suggest that disturbing rhythms is associated with increased risk of heart disease and worse outcome. 3, 4, 7, 17, 18 Moreover, we and others previously showed experimentally disturbing circadian rhythms in rodent models is an etiological cause of heart disease, and that rhythm disruption with preexisting heart disease leads to worse outcomes. [19] [20] [21] [22] However, the majority of these studies are done in males, and very little is known about the effect of biological sex on circadian rhythms and heart disease with age. This is important as the prevalence of cardiovascular disease remains lower in females until 75 years of age at which point it is similar between males and females. 23 Here, we examined the role of CLOCK, a core component of the circadian mechanism, 24 and a key regulator of cardiac gene and protein rhythms, 25, 26 in cardiac aging in females. We previously showed that Clock D19/D19 male mice develop profound cardiomyopathy with aging,
showing that an intact circadian mechanism is crucial for cardiac aging. 19 Remarkably we show here that female Clock D19/D19 mice are protected from the development of age-dependent heart disease, despite disruption of CLOCK function. We show that female biological sex and ovarian hormones play a role in mitigating the development of heart disease, even when there is a disturbed circadian mechanism. Conversely, loss of ovarian hormones in female Clock D19/D19 mice recapitulates the male cardiac phenotype of exacerbated cardiac aging. These findings are important as they show, for the first time, how ovarian hormones and the circadian mechanism interact to influence healthy cardiac aging.
Methods

Animals
All studies were approved by the University of Guelph Institutional Animal Care and Use Committee and in accordance with the guidelines of the Canadian Council on Animal Care. Female and male homozygote Clock D19/D19 heterozygote Clock D19/þ , and wild type (WT) littermates on a C57Bl/6 J background used for this study were obtained from our breeding colony at the University of Guelph, and genotyped as described previously in. 20, 25 Mice were housed on a 12-h light: 12-h dark (12:12 LD) cycle with food and water provided ad libitum throughout the study. All animals were sacrificed by isoflurane and cervical dislocation. Hearts for histopathology were perfused with 1 M KCl and fixed in 10% neutral buffered formalin. For all molecular experiments hearts were collected, snap frozen in liquid nitrogen and stored at -80 C until use. For determination of wheel running circadian period, individually housed mice were entrained to a diurnal 12:12 LD cycle for 2 weeks, followed by transfer to constant darkness (DD) for 3 weeks. Data were analysed using ClockLab (ActiMetrics).
Ovariectomy surgery
Bilateral ovariectomy was performed using the method of ClippertonAllen AE et al. 27 Briefly, 6-week-old mice were administered carprofen (20 mg/kg; Rimadyl, Pfizer) 1 h prior to the procedure for analgesia. Mice were anesthetized at 4% isoflurane and maintained at 2.5% using a nosecone. A small vertical midline dorsal incision of 2 cm was made in the lower back followed by two smaller bilateral lumbar incisions (<1 cm) through the muscles overlying the ovaries. The fallopian tubes and ovarian arteries were clamped and the ovaries excised. The central incision in the skin was closed with 1-2 MikRon Autoclip 9 mm wound clips (MikRon Precision Inc). Mice received a post-operative saline bolus (0.5 ml, subcutaneous) and recovered.
Echocardiography
Echocardiography was performed at 4, 8, 12, 18, and 21 months of age using a GE Vivid 7 Dimension ultrasound machine (GE Medical Systems) with the i13L 14 MHz linear-array transducer, as described in. 19, 20 Animals were maintained under light anesthesia (1.5% isoflurane) and body temperature maintained at 37 C during image acquisition. Data analyses were performed on an offline system using EchoPAC (GE Medical Systems).
In vivo haemodynamics
The homozygote Clock D19/D19 heterozygote Clock D19/þ and WT mice at 4 and 21 months of age were anesthetized using 4% isoflurane, intubated, and haemodynamic measurements were taken as previously described. 19 LV contractile performance and blood pressure were measured using a 1.4 Fr pressure catheter (Transonic) via the right carotid artery. Body temperature was continuously monitored and maintained at 37 C. Data were analyzed using Lab Chart 7 (Colorado Creeks, US). 30 mice were used, n = 4-6 mice/group at 4 and 21 months of age.
Histology
For histological analyses, formalin fixed hearts from 21-month-old mice were collected, paraffin embedded, and 5 mm sections were taken at the mid papillary level. Sections were stained with Masson's trichrome for analysis of myocyte cross sectional area (MCSA), or picrosirius red for quantification of cardiac fibrosis. At least 100 myocytes were measured per heart, over at least three sections, with n = 4 hearts/group, using Image J v1.48 (NIH).
Comprehensive lab animal monitoring system
The comprehensive lab animal monitoring system (CLAMS) was used to examine daily rhythms in metabolism and physical activity of 12-monthold female Clock D19/D19 and WT mice, using the methods described previously in. 20 Animals were acclimatized to the chambers for 48 h after which metabolic parameters were measured for 24 h. Data were analysed using the Oxymax software (Columbus Instruments). A total of 14 mice were used, n = 8 for female Clock D19/D19 mice, and n = 6 for female WT.
Glucose tolerance test
At 12 months of age glucose tolerance tests were performed in mice fasted for 14 h. At either ZT02 or ZT14 glucose was injected at 2 g/kg body weight (BW) (i.p.). Blood glucose concentrations following glucose challenge were determined by tail vein sampling at baseline, 15, 30, 45, 60, 90 , and 120 min post-injection using a hand-held glucometer (Freestyle Lite, Abbot). A total of 24 mice were used, n = 6 for female Clock D19/D19 and n ¼ 6 for female WT, n = 6 for OVX female Clock
D19/D19
and n = 6 OVX female WT. In addition, the day/night rhythm in ad lib glucose levels was determined at ZT02 and ZT14 by drawing blood from the saphenous vein and testing on the hand-held glucometer (Freestyle Lite, Abbot). n = 10 female Clock D19/D19 mice and n = 9 female WT mice were used. 
Protein isolation and immunoblotting
Animals were sacrificed at ZT06 by isoflurane and cervical dislocation, and hearts were collected. Protein was isolated using the CelLytic MT Cell Lysis reagent (Sigma) supplemented with cOmplete protease and PhosSTOP phosphatase inhibitor cocktails (Roche), using methods previously described by our laboratory. 25, 26, 28 Total protein concentration was determined using the Bradford assay (Bio-Rad). Lysates were subjected to SDS-PAGE and transferred to a PVDF membrane (Bio-Rad) at 100 V for 2 h. Following transfer, membranes were blocked using 5% milk in tris-buffered saline with tween-20 (TBS-T) then incubated with the primary antibodies overnight at 4 C. Primary antibodies used were phospho-AKT (Ser473) (4060; 1:1000), or AKT (4691; 1:1000), or phospho-GSK-3b (Ser9) (9323; 1:1000), or GSK-3b (9315; 1:1000).
Membranes were then washed in TBS-T and incubated with a goat antirabbit-HRP secondary antibody (1:5000) for 1 h at room temperature. All antibodies were purchased from Cell Signalling. Membranes were then washed and proteins visualized by enhanced chemi-luminescence on a ChemiDoc MP (BioRad) using the SignalFire Elite ECL reagent (12757, Cell Signalling). Loading was normalized to total protein using the Mem-code PVDF kit (Thermo Scientific). Images were analyzed using ImageLab (BioRad). A total of 14 mice were used, n = 7 female WT, n = 7 female Clock D19/D19 .
2-Deoxyglucose and 2-bromopalmitate uptake
To assess glucose and fatty acid uptake in tissues in vivo, 12-month old mice were fasted for 14 h, then anesthetized at ZT06 with isoflurane, and injected retro-orbitally with 5 mCi 2-deoxyglucose in phosphate buffered saline (PBS) and 1.5 mCi 2-bromo [C 14 ]palmitate complexed to bovine serum albumin in PBS. Hearts were collected 1 h after injection, homogenized in PBS, and radioactivity measured by liquid scintillation counting (Tri-Carb 2900TR; Packard Instruments). Radioactivity in tissue homogenates was normalized to the counts per minute (cpm) present in 10 ml of serum collected 5 min following injection. A total of 19 mice were used, n = 5 male Clock D19/D19 n = 5 male WT, n = 4 female Clock D19/D19 and n = 5 female WT.
Lipidomics
Cardiac lipids were extracted from hearts collected at ZT06 according the Bligh and Dyer method, 29 
Cytochrome c activity assay
Animals were sacrificed at ZT06 by isoflurane and cervical dislocation, and hearts were collected. Mitochondria were isolated using the Mitochondrial Isolation Kit, according to the manufacturer's instructions (Sigma; MITOISO1). Total mitochondrial protein was determined using the Bradford assay (Bio-Rad). Cytochrome c Oxidase activity was determined using the CYTOCOX1 Assay kit (Sigma) according the manufacturer's instructions. The change in absorbance at 550 nm was measured in 1 ml cuvettes using a Helios Delta spectrophotometer (Thermo Scientific). A total of 40 mice were used, n = 7 male Clock D19/D19 n = 7 male WT, n = 7 female Clock D19/D19 n = 7 female WT, n = 6 OVX female Clock D19/D19 and n = 6 OVX female WT.
Statistical analysis
Values are expressed as mean ± SEM. All data were tested for normal distribution and homogenous of variance. Statistical comparisons were done using an unpaired Student's t-test, or two-way analysis of variance (ANOVA) followed by Tukey post hoc for multiple comparisons as applicable. Analyses were done using SigmaPlot 12 (Systat Software Inc.) and Prism 5 (Graph Pad). Values of *P < 0.05 are considered statistically significant.
Results
Female Clock D19/D19 mice are protected from cardiac aging
The female Clock D19/D19 mice have a disrupted circadian mechanism, yet remarkably, they are protected against heart disease with aging. In order to first characterize the disrupted circadian mechanism, we used the classical wheel running actigraphy methods. We show the day/night phenotypes of the homozygote Clock D19/D19 heterozygote Clock D19/þ and the WT mice. All animals entrain to the LD cycle under normal 12:12 LD conditions, as anticipated ( Figure 1A) . Moreover, under circadian conditions of constant darkness, where the animals receive their cues from the endogenous circadian mechanism instead of the light: dark cycle, the effect of the Clock mutation is clearly evident in the female mice. The Clock mutation leads to a significant increase in wheel running period in homozygote Clock D19/D19 mice (27.10 h ± 0.07) compared with heterozygote (24.27 h ± 0.05), and WT mice (23.83 h ± 0.03). This is very similar to the phenotype that has been previously well established in the male Clock mice, by our group and others. 19, 24 Moreover, we found that the onset of activity in homozygous Clock D19/D19 mice was more variable compared with the other genotypes, but there were no difference in the total amount of running wheel activity (see Supplementary material on line, Figure S1A and B). Collectively these data show that the Clock mutation is functional in the female mice.
To carefully evaluate cardiac structure and function in the aging female Clock D19/D19 Clock D19/þ , and WT mice, we used serial echocardiography at 4, 8, 12, 18, and 21 months of age. Figure 1 and Table 1 show that female Clock D19/D19 hearts are healthy to 18 months of age, as LV internal dimensions at diastole (LVIDd) ( Figure 1B ) and systole (LVIDs) ( Figure  1C ), % ejection fraction (EF) ( Figure 1D ), and % fractional shortening (FS) ( Figure 1E ) are similar to heterozygotes and WTs. This is in contrast to the male Clock D19/D19 mice which exhibit increased cardiac remodelling starting at 12 months of age. 19 Comparison of female cardiac morphometry at 12 months of age confirms that female mice show protection from the adverse cardiovascular effects of CLOCK disruption, as female 
Cardiac aging in female Clock
D19/D19
mice, by in vivo haemodynamics
The female Clock D19/D19 are protected from heart disease for almost their entire normal 2 year lifespan, and only at 21 months of age do they exhibit any changes in cardiac function by echocardiography ( Figure 1B- mice have decreased LV end systolic pressure (LVESP), decreased mean arterial pressure (MAP), and reduced dp/dt max and dp/dt min values by in vivo haemodynamics ( Table 2) . That is, the aged female Clock
mice exhibit hypotension (reduced afterload) and a decrease in myocardial contractility indices. Thus these data show that the female Clock
mice are protected from adverse changes in cardiac structure and function for most of their lifespan, in contrast to the male Clock
mice, 19 and only begin to decompensate with old age.
Cardiac aging in female Clock
D19/D19
mice, by histopathology
We also examined additional cardiovascular parameters in the female Clock D19/D19 mice at 4 and 21 months of age. The aging female mice exhibited no difference in HW, as compared with littermates ( Figure 1F ) suggesting that the hearts do not have increased hypertrophy with age. The HW:BW ratio was increased, but only because of the lower BW in these aged animals ( Figure 1G and Table 1 ). There was also no difference in MSCA, consistent with the lack of cardiac hypertrophy with age ( Figure 1H) . Histologically, however we did find greater cardiac fibrosis in the female Clock D19/D19 mice by 21 months, consistent with the onset of contractile dysfunction at 21 months ( Figure 1I ). 
Diurnal metabolism in female Clock
Since female Clock D19/D19 mice show protection from the adverse effects of CLOCK disruption on the heart by 12 months we further examined differences between male and female Clock D19/D19 and WT mice at this age. We investigated diurnal metabolic parameters in the female Clock D19/D19 vs. WT mice. Overall, the animals are nocturnal with increased activity in the dark phase, as anticipated ( Figure 2A) . All animals consume the majority of their food in the dark (active) phase; however, female Clock D19/D19 mice also consume significantly more food during the light (rest) phase than the female WTs ( Figure 2B) . Examination of whole body substrate utilization in female Clock D19/D19 mice reveals significantly greater respiratory exchange ratio (RER) during the light phase as compared with WTs ( Figure 2C ). There is no difference in oxygen consumption ( Figure 2D ), however energy expenditure is also significantly increased in Clock D19/D19 mice during the light phase as compared with WTs ( Figure   2E ). 
taking in more food, using more carbohydrates, but also expending more energy, as compared with their WT littermates. This is in contrast to male Clock D19/D19 mice which have been previously shown to exhibit increased food intake and reduced energy expenditure. Specifically, glucose tolerance testing at either ZT02 (rest phase) ( Figure  2F ) or ZT14 (wake phase) ( Figure 2G ) revealed peak glucose levels at 15 min post-glucose injection, followed by similar rates of glucose clearance to 2 h after injection in female Clock D19/D19 and WT mice.
Consistent with normal glucose clearance, the area under the curve (AUC) is similar in female Clock D19/D19 and WT mice at ZT02 or ZT14
( Figure 2H) . Moreover, examination of blood glucose levels under ad libitum conditions demonstrated that both groups have normal diurnal blood glucose levels, as measured at ZT02 and ZT14 ( Figure 2I ). These findings are significant because the female Clock D19/D19 mice maintain normal blood glucose responses and are protected from heart disease, which is in contrast, to previous work which showed that male Clock D19/D19 mice have abnormal glucose handling with aging. vs. male Clock D19/D19 mice Since the studies above indicated that the female Clock D19/D19 mice have differences in energy and glucose profiles as compared with the male Clock D19/D19 mice, and since this might help to explain why the females are protected from heart disease, we next investigated tissue substrate uptake by radiolabelled glucose and palmitate assays. In the heart, we found that female Clock D19/D19 mice maintain normal cardiac 3 H-deoxyglucose and 14C-palmitate uptake with aging, similar to female WT mice ( Figure 3A) . In contrast, male Clock D19/D19 mice have significantly increased cardiac glucose uptake compared with male WT mice ( Figure 3A) . In the liver, we found that female Clock D19/D19 mice also maintain normal cardiac 3 H-deoxyglucose and 14C-palmitate uptake with aging, similar to female WT mice ( Figure 3B) . However, the male Clock D19/D19 mice have significantly increased liver substrate uptake compared with male WT mice ( Figure 3B) . Last, in skeletal muscle, we found that female Clock D19/D19 mice handle glucose the same, but have significantly reduced skeletal muscle fatty acid uptake, as compared with female WT mice ( Figure 3C ). The males again are different; male Clock
D19/D19
mice had no change in fatty acid skeletal muscle uptake compared with male WT mice ( Figure 3C) . Collectively, these data demonstrate that female Clock D19/D19 mice maintain normal substrate uptake with aging, which may help to protect them from heart disease, whereas the male Clock D19/D19 mice have altered glucose and fatty acid uptake compared with male WTs that could play a role in the pathogenesis of age-dependent heart disease.
Cardiac lipidomics
Previously we found a role for cardiac lipids in mediating sex-differences in cardiac remodelling with aging in a different study which focused on lipid metabolism; however, we did not investigate the circadian system at that time. 32 The lipid composition of cells is influenced by ovarian hormones 33, 34 and ovarian hormones can protect against heart disease.
35-37
In light of those observations, we next investigated the lipid composition of the hearts of the female and male Clock D19/D19 mice and controls. We performed shotgun lipidomics (DI-MS/MS) to investigate the cardiac lipidome in aged mice. We were specifically interested in lipid profiles that were common to the female WTs, female Clock D19/D19 and male WTs, but altered in the male Clock D19/D19 animals with age-dependent cardiomyopathy. Total lipid content was extracted from the hearts, followed by Biological sex influences heart disease in Clock mice Biological sex influences heart disease in Clock mice mass spectrometry. Lipid View bioinformatics was used to compile the results into the following groupings: phospholipids, triacylgylceride fatty acids, phospholipid fatty acids, and cardiolipins. We found general differences in lipid content between male and female mice, as anticipated 32 (see Supplementary material online, Tables S1 and S2). We also found differences in cardiolipin composition consistent with our hypothesis that lipid content varies with cardiovascular remodelling in heart disease. Specifically, we found that the primary cardiolipin CL72:8 was lowest in male Clock D19/D19 hearts ( Figure 4A ) compared with all other groups.
Moreover, we found a shift in composition of the less abundant cardiolipins. These changes include cardiolipin CL76:11 which were increased in male Clock D19/D19 mice vs. all other groups ( Figure 4B ). In addition, cardiolipin CL82:9 was increased and cardiolipin CL74:9 was decreased in male Clock D19/D19 mice with heart disease as compared with healthy male WT mice ( Figures 4C and D) . Collectively, these data show remodelling of lipid profiles which correlate with increased cardiac remodelling in male Clock D19/D19 mice.
Activation of cardiac hypertrophy pathways
A mechanism by which disrupting CLOCK can promote cardiac aging is through the AKT and GSK-3 b signalling pathway; indeed we previously reported this in the male Clock D19/D19 mice. 19 Thus we next investigated these pathways in the female Clock D19/D19 mice as differential activation might help to explain why the females are protected from agedependent cardiac remodelling. Interestingly, we found that female Clock D19/D19 mice exhibit a significant increase in AKT activation compared with female WT mice ( Figure 4E ), suggesting that CLOCK disruption affects AKT activation regardless of sex. Moreover, GSK-3b phosphorylation was also significantly increased in female Clock
D19/D19
hearts, consistent with increased AKT activation in these mice ( Figure  4E) . Interestingly, despite differences in the AKT/GSK phosphorylation pathways, the female Clock D19/D19 mice maintained cytochrome c oxidase activity similar to female WT littermates ( Figure 4F) . This is in contrast male Clock D19/D19 hearts, which have reduced cytochrome c oxidase activity compared with male WT littermates ( Figure 4F) . Taken together, these results show that female Clock D19/D19 mice have activation of AKT/GSK pathways consistent with the presence of the Clock mutation, however this does not lead to changes in cytochrome c oxidase activity as was found in the development of age-dependent cardiomyopathy in male Clock D19/D19 mice ( Figure 4G ). Consistent with this finding, they also show no changes in cardiac glucose uptake and mitochondrial function ( Figure 4G ), which may help to explain the cardioprotection despite the Clock mutation.
OVX female Clock D19/D19 mice exhibit age-dependent cardiac remodelling
We next hypothesized that ovarian hormones play a protective role and that ovariectomy of female Clock D19/D19 mice should remove the protective effect and lead to the development age-dependent cardiac remodelling. To examine this, female Clock D19/D19 mice were ovariectomized (OVX) at 6 weeks of age, and their cardiac structure and function were evaluated as these animals aged and were compared with WT OVX mice. We found that OVX female Clock D19/D19 mice by 8 months of age develop significantly increased left ventricular dilation evidenced by increased LVIDd ( Figure 5A ) and LVIDs ( Figure 5B) , as compared with OVX WT littermates. The hearts continued to dilate by 12 months of age ( Figures 5A and B) , and HW is significantly increased ( Figure 5C ). In addition, the female OVX Clock D19/D19 mice no longer maintain normal blood glucose responses as intact females had, but instead show abnormal glucose handling. That is, at ZT02 (lights on, animal rest time), OVX Clock D19/D19 mice had increased blood glucose levels post-injection, as compared with OVX WT mice ( Figure 5D) . Moreover, at ZT14 (lights off, animal wake time), OVX Clock D19/D19 mice also had increased blood glucose levels post-injection as compared with OVX WT mice ( Figure 5E ). Consistent with glucose intolerance in the OVX Clock D19/D19 mice, AUC was significantly increased at ZT02 and ZT14, as compared with OVX WT mice ( Figure 5F ). Last, we examined cytochrome c oxidase activity and found that the OVX Clock D19/D19 mice have reduced cytochrome c oxidase activity compared with OVX WT mice ( Figure 5G) . Thus the loss of ovarian hormones in female Clock D19/D19 mice recapitulates the heart disease phenotype, and metabolic dysregulation observed in male Clock D19/D19 mice, and is consistent with a role of Clock in cardiac remodelling with age.
Discussion
In this study, we demonstrate that female Clock D19/D19 mice are protected from the development of age-dependent heart disease, despite the presence of the Clock mutation. Female Clock D19/D19 hearts appear (n = 6 hearts/group), *P < 0.05 as indicated and †P < 0.05 vs. all other groups by two way ANOVA followed by Tukey post hoc. (E) Western blots of phospho-AKT (S473), total AKT, phospho-GSK-3b (S9), total GSK-3b and total protein in female Clock D19/D19 and WT mice at 12 months of age (n = 7 hearts/ group), *P < 0.05 by unpaired Student's t-test. (F) Cytochrome c oxidase activity in mitochondria isolated from female and male Clock D19/D19 and WT hearts (n = 7/group), *P < 0.05 by two-way ANOVA followed by Tukey post hoc. profiles, which may help protect against underlying genetic dysfunction. One of the interesting findings of this study is that the adverse effects of the circadian Clock mutation on the heart can be mitigated by female biological sex and ovarian hormones. Several recent circadian studies using genetic or environmental models provide further support for a role of biological sex in mediating the effects of circadian rhythm disruption, consistent with our findings. For example, human females exhibit greater impairment in cognitive performance following circadian dysynchrony, as compared with males in similar environments. 38 In experimental animal models, survivorship after myocardial infarction is greater in female mice as compared with male mice, 39 and more specifically females infarcted at sleep time have the greatest survivorship. 40 It has also been shown that female Clock D19/D19 mice exhibit lower survival following whole body irradiation compared with female WT mice while male Clock D19/D19 mice do not show changes in survival as compared with male WT mice. 41 Last, circadian disorganization caused by shifted light dark cycles leads to reduced survival of male rats but not female rats following middle cerebral artery occlusion. 42 Thus Clock disruption may interact with factors associated with biological sex to modulate the pathologic effects of heart disease. This is the first study to show a role for biological sex in mitigating the effects of the Clock mutation on cardiac remodelling. However, the notion that females are protected from cardiovascular disease in general is well established. 23, 43, 44 For example females are protected from heart disease as compared with males, with reduced cardiac remodelling in aging female rats 45 and also less hypertrophy in pressure overloadinduced cardiac hypertrophy in female mice. 46 Metabolism also plays a role in male-female differences in heart disease. 47 These can be driven in part by differences in glucose handling, 48, 49 cardiac glucose uptake, 50 and fatty acid oxidation profiles. 51 In terms of our study, altered substrate utilization/cardiac lipid profiles and reduced cytochrome c oxidase activity were associated with the development of age-dependent cardiomyopathy in male Clock D19/D19 mice, whereas female Clock D19/D19 mice do not exhibit these metabolic changes and are protected from the development of heart disease with age. One key aspect we found is that there were differences in the remodelling of cardiolipin profiles in a sex and genotype manner.
Cardiolipins are a key component of the inner mitochondrial membrane important for mitochondrial bioenergetics, 52 and composition is altered in heart disease. 53 Our female Clock D19/D19 mice maintain normal cardiolipin profiles and lack heart disease. In contrast, we observed changes in cardiolipin profiles in the male Clock D19/D19 mice. Cardiolipin profiles in the male Clock D19/D19 mice are consistent with those reported in heart disease, as reduced 72:8 and increased 76:11 cardiolipin are associated with heart failure in humans, and experimental heart failure in rats. 53 Moreover, reduced 72:8 content is associated with reduced cytochrome c oxidase activity. 53 Collectively these studies suggest that remodelling of cardiolipins leads to impaired mitochondrial function in male Clock D19/D19 mice. Conversely, female Clock D19/D19 mice are protected from age-dependent heart disease, mediated in part by preserved cardiolipin content and cytochrome c oxidase activity. We postulate that the ovarian hormones protect against the decline in mitochondrial function, reducing age-dependent cardiac remodelling. In terms of future directions, it will be interesting to investigate serum lipid profiles as well as the cardiac metabolome in female verses male Clock D19/D19 mice to further understand how female mice are metabolically protected from the Clock mutation.
It is interesting to note that there are differences in the ability of the skeletal muscle to utilize fatty acids compared with the heart in Clock D19/ D19 mice. Assuming that increase in whole body RER is reflecting a reduction in skeletal muscle metabolism of fatty acids, there is no compensatory increase in glucose metabolism. One possible explanation for this differential regulation is that these changes in substrate profiles are the result of an interaction between tissue specific circadian regulation and cardiac specific changes associated with disease progression. In support of this Zhang et al. have shown that rhythmic gene expression is regulated in a tissue specific manner, including genes critical for glucose and fatty acid metabolism. 54 Moreover, the circadian clock has been shown to regulate genes crucial for substrate utilization in the heart 55 and skeletal muscle 56 which likely contributes to tissue specific regulation. Last, there are changes in cardiac metabolism associated with heart disease including increased glucose utilization, as observed in male Clock D19/D19 mice. 57, 58 Collectively, these factors can help to explain why there is differential regulation of glucose and fatty acids between the heart and skeletal muscle. Moreover, ovarian hormone regulation of circadian gene expression and cardiac remodelling may explain why females are protected against the metabolic derangement and cardiomyopathy with aging.
Although the female Clock D19/D19 mice are protected from heart disease, OVX Clock D19/D19 mice develop age-dependent cardiac remodelling, consistent with a role for Clock in this disease process. This is consistent with the notion that ovarian hormones protect against heart disease. For example, estrogen mitigates mechanisms of cardiomyocyte hypertrophy, as demonstrated in rat cardiomyocytes in vitro. 36 Moreover, estrogen replacement limits cardiomyocyte hypertrophy in vitro, and preserves LV function and contractility in mice with pressure overload-induced cardiac hypertrophy in vivo. 37 Estrogens can interact with the intrinsic circadian clock, and prevent abnormal metabolic profiles caused by circadian disruption 59 which helps to explain why our female mice with a Clock mutation were protected. However, it's important to note that OVX leads to a loss of a variety of hormones. Although beyond the scope of this study, it would be interesting in future studies to examine how the different hormones interact with Clock, and other components of the circadian mechanism to provide cardio-protection with aging. For example, future studies using estrogen supplementation as well as estrogen receptor specific agonists in OVX Clock D19/D19 mice will help delineate the pathways responsible for cardio-protection. Interestingly, we have recently shown that female mice are less susceptible to adverse remodelling after myocardial infarction (LAD ligation model) as compared with male mice. 40 Given that increased AKT activation in the heart is associated with circadian clock disruption in male 19, 60 and female mice, it could be interesting to determine sex-dependent differences in disease pathophysiology in this model as well in trans-aortic constriction, where AKT signalling is also crucial.
Although female biological sex confers some protection against the circadian Clock mutation and heart disease in female mice, the males are not protected. This has important clinical implications, particularly as circadian rhythm disruption (e.g. in shift work, sleep disorders) is associated with increased risk of cardiovascular disease and worse outcomes, especially in males. 3, 4, 7, 15, 16 In addition, circadian timing of drug treatment (chronotherapy) benefits the efficacy of some cardiovascular therapies such as angiotensin converting enzyme inhibitors, and Aspirin. 54, [61] [62] [63] [64] However, there are important sex differences that should be considered, as the benefits of chronotherapy differ between male and female patients. 65, 66 Moreover, circadian mechanism modulators are currently under development 67, 68 and hold therapeutic promise for reducing the progression of heart disease; therapeutic benefits and potential side effects should be investigated in both sexes. Therefore future investigation of how biological sex and the circadian mechanism interact to influence cardiac remodelling is critical for understanding the pathophysiology of heart disease and for clinical benefit in males and females.
Conclusion
In summary, we show the first time that female Clock D19/D19 mice are protected from the adverse effects of the Clock mutation and the development of age-dependent heart disease. Furthermore, we show that ovarian hormones play a key role in mediating the protective effects in female Clock D19/D19 mice, as ovariectomy of Clock D19/D19 mice recapitulates the phenotype of metabolic dysfunction and adverse cardiac remodelling with age. These data demonstrate a previously unrecognized link between biological sex and Clock in the development and protection against heart disease with aging.
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